Biologics World Taiwan 2027 (Solution Providers)

Thirteen years in, this is still Taiwan's room for biologics people. Manufacturing, R&D and clinical trials teams come together in Taipei for two days, and this pass gets solution providers in with them. If you sell CDMO capacity, bioprocess tools, AI platforms or clinical services, these are the people you'll want to talk to.

What's on the table

The sessions go deep, not wide. Expect to hear about:

• AI-driven innovation in biologics R&D

• Scaling up biomanufacturing capacity with strong CDMO partners

• Gene and cell therapy, including CAR-T and stem cell applications

• Optimising upstream and downstream processes

• Case studies on mRNA, HIV and dengue vaccine development

• Taiwan's plan for expanding into the global biotech market

If your product fixes a problem on that list, you'll have plenty to talk about. If it fixes several, you may need extra business cards.

Why Taipei, why now

Taiwan is putting real weight behind becoming a biomanufacturing hub. The goal is to repeat its semiconductor success in biotech, and that means building domestic CDMO capacity for advanced biologics. For anyone supplying that build-out, this is where the local buyers, builders and decision-makers gather.

The essentials

The exact venue address hasn't been published yet, so keep an eye on the organizer's event page for the details. Then book your Solution Provider pass, pack your pitch deck and come meet the people building Taiwan's biologics pipeline.